NightHawk Biosciences, Inc
Research - Morrisville, North Carolina, United States
NightHawk Biosciences, Inc Employees
NightHawk Biosciences, Inc Senior Management
NightHawk Biosciences, Inc Details
Heat Biologics, Inc (NASDAQ: HTBX) is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. The company's gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in its Phase 2 trial, and a COVID-19 vaccine program in preclinical development. In addition, Heat is also developing a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials.
NightHawk Biosciences, Inc Technologies
Email Providers
Gmail
Domain Name Services
Route 53
Other
Mobile Friendly
Hosting
Amazon AWS